These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 38819524)

  • 1. The most common skin symptoms in young adults and adults related to SARS-CoV-2 virus infection.
    Zaborska M; Chruszcz M; Sadowski J; Klaudel T; Pelczarski M; Sztangreciak-Lehun A; Bułdak RJ
    Arch Dermatol Res; 2024 May; 316(6):292. PubMed ID: 38819524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and dermatology.
    Gül Ü
    Turk J Med Sci; 2020 Dec; 50(8):1751-1759. PubMed ID: 32599968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations.
    Garduño-Soto M; Choreño-Parra JA; Cazarin-Barrientos J
    Arch Dermatol Res; 2021 Oct; 313(8):611-622. PubMed ID: 33159236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review.
    Fernández-Lázaro D; Garrosa M
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature.
    Dondi A; Sperti G; Gori D; Guaraldi F; Montalti M; Parini L; Piraccini BM; Lanari M; Neri I
    Eur J Pediatr; 2022 Oct; 181(10):3577-3593. PubMed ID: 35948654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection.
    Burlando M; Russo R; Cozzani E; Parodi A
    Dermatol Ther; 2021 Jan; 34(1):e14641. PubMed ID: 33278049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.
    Gisondi P; PIaserico S; Bordin C; Alaibac M; Girolomoni G; Naldi L
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2499-2504. PubMed ID: 32585074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge.
    Mohseni Afshar Z; Babazadeh A; Hasanpour A; Barary M; Sayad B; Janbakhsh A; Aryanian Z; Ebrahimpour S
    J Med Virol; 2021 Oct; 93(10):5756-5767. PubMed ID: 34241899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous manifestations in patients with coronavirus disease 2019: clinical and histological findings.
    Fattori A; Cribier B; Chenard MP; Mitcov M; Mayeur S; Weingertner N
    Hum Pathol; 2021 Jan; 107():39-45. PubMed ID: 33161030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents.
    Franulić D; Parać E; Dolački L; Topalušić I; Lugović-Mihić L
    Acta Dermatovenerol Alp Pannonica Adriat; 2023 Dec; 32(4):173-181. PubMed ID: 38126100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management.
    Masood W; Ahmad S; Khan NA; Shakir A; Rokni GR; Gold MH; Cockerell CJ; Schwartz RA; Goldust M
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Manifestations of COVID-19: A Systematic Review.
    Singh H; Kaur H; Singh K; Sen CK
    Adv Wound Care (New Rochelle); 2021 Feb; 10(2):51-80. PubMed ID: 33035150
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 and cutaneous manifestations: A review of the published literature.
    Martora F; Villani A; Fabbrocini G; Battista T
    J Cosmet Dermatol; 2023 Jan; 22(1):4-10. PubMed ID: 36342945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).
    Carrascosa JM; Morillas V; Bielsa I; Munera-Campos M
    Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):734-742. PubMed ID: 32882184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.
    Ricardo Criado P; Pincelli TPH; Criado RFJ; Abdalla BMZ; Belda Junior W
    Exp Dermatol; 2020 Oct; 29(10):936-944. PubMed ID: 32867008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Diseases Associated With COVID-19: A Narrative Review.
    Kostopoulos-Kanitakis KA; Kanitakis J
    Cutis; 2023 Apr; 111(4):E19-E27. PubMed ID: 37289699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous lesions in COVID-19 patients].
    Çiftçi Z; Clabbers JMK; Galimont-Collen AFS; Gostyński A
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous manifestations in patients with COVID-19 with significant attention to urticaria].
    Sánchez-Borges M; González-Díaz SN; Ortega-Martell JA; Rojo-Gutiérrez MI; Ansotegui-Zubeldia IJ
    Rev Alerg Mex; 2021; 68(2):112-116. PubMed ID: 34525782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, clinical profiles, and prognostic value of COVID-19-related cutaneous manifestations in African populations: a rapid narrative review.
    Nyasulu PS; Tamuzi JL
    Int J Dermatol; 2024 Jan; 63(1):10-22. PubMed ID: 37965793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatological manifestations during COVID-19 infection: a case series and discussion on the problem of differential diagnosis.
    Ridolo E; Pucciarini F; Barone A; Nouvenne A; Meschi T; Peveri S; Incorvaia C
    Acta Biomed; 2021 Feb; 92(1):e2021103. PubMed ID: 33682815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.